Anti-Ro/SS-A antibody is associated with worse pulmonary outcome and reduced overall survival in systemic sclerosis.
Mod Rheumatol
; 32(6): 1086-1093, 2022 Oct 15.
Article
in En
| MEDLINE
| ID: mdl-34927207
Key words
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Main subject:
Scleroderma, Systemic
/
Sjogren's Syndrome
/
Scleroderma, Diffuse
Type of study:
Diagnostic_studies
/
Observational_studies
/
Prognostic_studies
/
Risk_factors_studies
Limits:
Female
/
Humans
/
Male
/
Middle aged
Language:
En
Journal:
Mod Rheumatol
Year:
2022
Document type:
Article
Affiliation country:
Country of publication: